BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17379155)

  • 1. Management of oral lesions in HIV-positive patients.
    Baccaglini L; Atkinson JC; Patton LL; Glick M; Ficarra G; Peterson DE
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S50.e1-23. PubMed ID: 17379155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of expression of HHV8, EBV and HPV in selected HIV-associated oral lesions.
    Hille JJ; Webster-Cyriaque J; Palefski JM; Raab-Traub N
    Oral Dis; 2002; 8 Suppl 2():161-8. PubMed ID: 12164651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral lesions of the mouth in HIV-infected patients.
    Itin PH; Lautenschlager S
    Dermatology; 1997; 194(1):1-7. PubMed ID: 9031782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS and the gateway of the body.
    Bandyopadhyay P; Bhowal RN; Sikdar SN; Roy AK; Roy JG; Bandyopadhyay D; Pal NC; Chatterjee BD
    J Indian Med Assoc; 1994 Jan; 92(1):17-9. PubMed ID: 8207272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group.
    Romanowski B; Aoki FY; Martel AY; Lavender EA; Parsons JE; Saltzman RL
    AIDS; 2000 Jun; 14(9):1211-7. PubMed ID: 10894286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral manifestations of HIV infection.
    Greenspan D; Greenspan JS
    AIDS Clin Care; 1997 Apr; 9(4):29-33. PubMed ID: 11364217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral ulcer as primary manifestation of HIV infection in an 80-year-old man].
    Ludvigsen LU; Søgaard OS
    Ugeskr Laeger; 2014 Dec; 176(25A):. PubMed ID: 25497664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D; Scott LJ; Perry CM
    Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge, attitudes and practices of oral health care workers in Lesotho regarding the management of patients with oral manifestations of HIV/AIDS.
    Ramphoma KJ; Naidoo S
    SADJ; 2014 Nov; 69(10):446, 448-53. PubMed ID: 26506796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral lesions associated with human immunodeficiency virus disease.
    Patton LL
    Dent Clin North Am; 2013 Oct; 57(4):673-98. PubMed ID: 24034072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of oral and perioral manifestations in HIV positive adults at Tikur Anbessa Teaching Hospital Addis Ababa, Ethiopia.
    Guteta S; Feleke Y; Fekade D; Neway M; Diro E
    Ethiop Med J; 2008 Oct; 46(4):349-57. PubMed ID: 19271399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of oral health in persons with HIV infection.
    Scully C; McCarthy G
    Oral Surg Oral Med Oral Pathol; 1992 Feb; 73(2):215-25. PubMed ID: 1312692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical management of selected oral fungal and viral infections during HIV-disease.
    Reichart PA
    Int Dent J; 1999 Oct; 49(5):251-9. PubMed ID: 10858761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral manifestations of HIV disease.
    Reznik DA
    Top HIV Med; 2005 Dec-2006 Jan; 13(5):143-8. PubMed ID: 16377852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
    Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
    J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population.
    Bravo IM; Correnti M; Escalona L; Perrone M; Brito A; Tovar V; Rivera H
    Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E33-9. PubMed ID: 16388291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS?
    Ceballos-Salobreña A; Gaitán-Cepeda LA; Ceballos-Garcia L; Lezama-Del Valle D
    AIDS Patient Care STDS; 2000 Dec; 14(12):627-35. PubMed ID: 11119429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation on oral lesions in 64 Chinese HIV/AIDS patients in Guangxi province].
    Tao RC; Deng HJ; Ya ZK; Guo SZ; Liang SX; Liu W
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2005 Aug; 23(4):338-40. PubMed ID: 16178201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Oral HIV/AIDS Research Alliance: updated case definitions of oral disease endpoints.
    Shiboski CH; Patton LL; Webster-Cyriaque JY; Greenspan D; Traboulsi RS; Ghannoum M; Jurevic R; Phelan JA; Reznik D; Greenspan JS;
    J Oral Pathol Med; 2009 Jul; 38(6):481-8. PubMed ID: 19594839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomized clinical trial.
    Ramírez-Amador V; Esquivel-Pedraza L; Lozada-Nur F; De la Rosa-García E; Volkow-Fernández P; Súchil-Bernal L; Mohar A
    Oral Oncol; 2002 Jul; 38(5):460-7. PubMed ID: 12110340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.